Deena Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Revenue Growth %
- Profit Growth -34.19%
- Ebitda 24.75%
- Net Worth 63.07%
- Total Assets 58.58%
About Deena Life Science
Deena Life Science Private Limited (DLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 June 2022 (Two years and seven months 4 days old ). Its registered office is in Lower Subansiri, Arunachal Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.00 Cr.
Pramod Bagrodia, Posting Bayang, and Tame Sime serve as directors at the Company.
Company Details
- Location
Lower Subansiri, Arunachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110AR2022PTC013769
- Company No.
013769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Deena Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Bagrodia  | Director | 29-Jun-2022 | Current |
| Posting Bayang | Director | 29-Jun-2022 | Current |
| Tame Sime | Director | 29-Jun-2022 | Current |
Financial Performance of Deena Life Science.
Deena Life Science Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 34.19% decrease in profit. The company's net worth Soared by an impressive increase of 63.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deena Life Science?
In 2024, Deena Life Science had a public holding of 16.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2022 | State Bank Of India | ₹2.00 Cr | Open |
How Many Employees Work at Deena Life Science?
Deena Life Science has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deena Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deena Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.